NVMI vs. CLBT
NVMI (Nova Ltd) and CLBT (Cellebrite DI Ltd.) are both stocks. Both are in the Technology sector — NVMI in Semiconductor Equipment & Materials, CLBT in Software - Infrastructure. Over the past 3 years, NVMI returned 63.15%/yr vs 32.07%/yr for CLBT. At a 0.24 correlation, their price movements are largely independent.
Performance
NVMI vs. CLBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVMI achieves a 44.92% return, which is significantly higher than CLBT's -11.59% return.
NVMI
- 1D
- 0.40%
- 1M
- -14.96%
- 6M
- 20.77%
- YTD
- 44.92%
- 1Y
- 67.48%
- 3Y*
- 63.15%
- 5Y*
- 36.82%
- 10Y*
- 44.72%
CLBT
- 1D
- -1.18%
- 1M
- 24.14%
- 6M
- -13.65%
- YTD
- -11.59%
- 1Y
- 9.25%
- 3Y*
- 32.07%
- 5Y*
- —
- 10Y*
- —
NVMI vs. CLBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
NVMI Nova Ltd | 44.92% | 66.74% | 43.35% | 68.21% | -44.25% | 44.59% |
CLBT Cellebrite DI Ltd. | -11.59% | -18.16% | 154.39% | 98.62% | -45.64% | -23.40% |
Correlation
The correlation between NVMI and CLBT is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Aug 31, 2021 | 0.24 |
Over the past year, the correlation between NVMI and CLBT has dropped to 0.01 - well below their long-term average of 0.24, suggesting their price drivers have been diverging.
Fundamentals
NVMI:
$15.13B
CLBT:
$3.98B
NVMI:
$7.85
CLBT:
$0.29
NVMI:
60.61
CLBT:
55.70
NVMI:
2.10
CLBT:
0.11
NVMI:
17.71
CLBT:
8.06
NVMI:
11.81
CLBT:
7.87
NVMI:
$902.53M
CLBT:
$496.43M
NVMI:
$518.59M
CLBT:
$416.33M
NVMI:
$293.89M
CLBT:
$84.98M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVMI vs. CLBT — Risk / Return Rank
NVMI
CLBT
NVMI vs. CLBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nova Ltd (NVMI) and Cellebrite DI Ltd. (CLBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVMI | CLBT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.04 | ||
| Sortino ratioReturn per unit of downside risk | +1.04 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.08 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.60 | 0.19 | +2.41 |
| Martin ratioReturn relative to average drawdown | 7.43 | 0.38 | +7.05 |
Loading charts...
Drawdowns
NVMI vs. CLBT - Drawdown Comparison
The maximum NVMI drawdown since its inception was -98.22%, which is greater than CLBT's maximum drawdown of -67.74%. Use the drawdown chart below to compare losses from any high point for NVMI and CLBT.
Loading charts...
Drawdown Indicators
| NVMI | CLBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.22% | -67.74% | -30.48% |
Max Drawdown (1Y)Largest decline over 1 year | -26.29% | -43.61% | +17.32% |
Max Drawdown (3Y)Largest decline over 3 years | -40.79% | -57.58% | +16.79% |
Max Drawdown (5Y)Largest decline over 5 years | -52.76% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -52.76% | — | — |
Current DrawdownCurrent decline from peak | -21.42% | -38.69% | +17.27% |
Average DrawdownAverage peak-to-trough decline | -51.65% | -34.69% | -16.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.17% | 21.03% | -11.86% |
Volatility
NVMI vs. CLBT - Volatility Comparison
Nova Ltd (NVMI) has a higher volatility of 25.53% compared to Cellebrite DI Ltd. (CLBT) at 14.02%. This indicates that NVMI's price experiences larger fluctuations and is considered to be riskier than CLBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVMI | CLBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.53% | 14.02% | +11.51% |
Volatility (6M)Calculated over the trailing 6-month period | 45.01% | 41.91% | +3.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.12% | 53.17% | +3.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.47% | 50.35% | -1.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 43.91% | 50.35% | -6.44% |
Dividends
NVMI vs. CLBT - Dividend Comparison
Neither NVMI nor CLBT has paid dividends to shareholders.
Financials
NVMI vs. CLBT - Financials Comparison
This section allows you to compare key financial metrics between Nova Ltd and Cellebrite DI Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVMI vs. CLBT - Profitability Comparison
NVMI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Nova Ltd reported a gross profit of 135.69M and revenue of 235.31M. Therefore, the gross margin over that period was 57.7%.
CLBT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Cellebrite DI Ltd. reported a gross profit of 105.88M and revenue of 128.30M. Therefore, the gross margin over that period was 82.5%.
NVMI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Nova Ltd reported an operating income of 70.84M and revenue of 235.31M, resulting in an operating margin of 30.1%.
CLBT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Cellebrite DI Ltd. reported an operating income of 9.23M and revenue of 128.30M, resulting in an operating margin of 7.2%.
NVMI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Nova Ltd reported a net income of 69.26M and revenue of 235.31M, resulting in a net margin of 29.4%.
CLBT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Cellebrite DI Ltd. reported a net income of 10.94M and revenue of 128.30M, resulting in a net margin of 8.5%.
Frequently Asked Questions
NVMI and CLBT have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVMI has higher volatility (25.53%) compared to CLBT (14.02%). In terms of maximum drawdown, NVMI dropped -98.22% vs CLBT's -67.74%.
NVMI currently has the higher Sharpe Ratio (1.20 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVMI and CLBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer